Ebola virus convalescent blood products: Where we are now and where we may need to go
Open Access
- 15 October 2014
- journal article
- review article
- Published by Elsevier BV in Transfusion and Apheresis Science
- Vol. 51 (2), 120-125
- https://doi.org/10.1016/j.transci.2014.10.003
Abstract
No abstract availableKeywords
This publication has 58 references indexed in Scilit:
- Serologic Cross-Reactivity of Human IgM and IgG Antibodies to Five Species of Ebola VirusPLoS Neglected Tropical Diseases, 2011
- A comparison of methods of pathogen inactivation of FFPVox Sanguinis, 2011
- Convalescent transfusion for pandemic influenza: preparing blood banks for a new plasma product?Transfusion, 2010
- Characterization of plasma protein activity in riboflavin and UV light-treated fresh frozen plasma during 2 years of storage at −30°CVox Sanguinis, 2010
- New methods of plasma fractionation – a presentation of the ‘mini‐pool’ fractionation procedure developed in EgyptISBT Science Series, 2009
- Epitopes Required for Antibody‐Dependent Enhancement of Ebola Virus InfectionThe Journal of Infectious Diseases, 2007
- Measles‐Virus–Neutralizing Antibodies in Intravenous ImmunoglobulinsThe Journal of Infectious Diseases, 2006
- Purification of severe acute respiratory syndrome hyperimmune globulins for intravenous injection from convalescent plasmaTransfusion, 2005
- Use of convalescent plasma therapy in SARS patients in Hong KongEuropean Journal of Clinical Microbiology & Infectious Diseases, 2004
- CONVALESCENT SERUM IN PROPHYLAXIS OF MEASLESBMJ, 1931